H.B. 191 Controlled Substance Abuse Amendments

Bill Sponsor:

Rep. Eliason, Steve
Floor Sponsor:

Sen. Vickers, Evan J.
  • Drafting Attorney: Daniel M. Cheung
  • Fiscal Analyst: Clare Tobin Lence



  • Information
    • Last Action: 22 Mar 2019, Governor Signed
    • Last Location: Lieutenant Governor's office for filing
    • Effective Date: 14 May 2019
    • Session Law Chapter: 130


H.B. 191

1     
CONTROLLED SUBSTANCE ABUSE AMENDMENTS

2     
2019 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Steve Eliason

5     
Senate Sponsor: Evan J. Vickers

6     

7     LONG TITLE
8     General Description:
9          This bill amends the Utah Controlled Substances Act.
10     Highlighted Provisions:
11          This bill:
12          ▸     requires a prescriber to discuss the risks of using an opiate with a patient or the
13     patient's guardian before issuing an initial opiate prescription.
14     Money Appropriated in this Bill:
15          None
16     Other Special Clauses:
17          None
18     Utah Code Sections Affected:
19     ENACTS:
20          58-37-19, Utah Code Annotated 1953
21     

22     Be it enacted by the Legislature of the state of Utah:
23          Section 1. Section 58-37-19 is enacted to read:
24          58-37-19. Opiate prescription consultation.
25          (1) As used in this section:
26          (a) "Hospice" means the same as that term is defined in Section 26-21-2.
27          (b) "Initial opiate prescription" means a prescription for an opiate to a patient who:
28          (i) has never previously been issued a prescription for an opiate; or
29          (ii) was previously issued a prescription for an opiate, but the date on which the current

30     prescription is being issued is more than one year after the date on which an opiate was
31     previously prescribed or administered to the patient.
32          (c) "Prescriber" means an individual authorized to prescribe a controlled substance
33     under this chapter.
34          (2) Except as provided in Subsection (3), a prescriber may not issue an initial opiate
35     prescription without discussing with the patient, or the patient's parent or guardian if the patient
36     is under 18 years of age and is not an emancipated minor:
37          (a) the risks of addiction and overdose associated with opiate drugs;
38          (b) the dangers of taking opiates with alcohol, benzodiazepines, and other central
39     nervous system depressants;
40          (c) the reasons why the prescription is necessary;
41          (d) alternative treatments that may be available; and
42          (e) other risks associated with the use of the drugs being prescribed.
43          (3) This section does not apply to a prescription for:
44          (a) a patient who is currently in active treatment for cancer;
45          (b) a patient who is receiving hospice care from a licensed hospice; or
46          (c) a medication that is being prescribed to a patient for the treatment of the patient's
47     substance abuse or opiate dependence.
Bill Status / Votes
• Senate Actions • House Actions • Fiscal Actions • Other Actions
DateActionLocationVote
1/28/2019 Bill Numbered but not DistributedLegislative Research and General Counsel
1/28/2019 Numbered Bill Publicly DistributedLegislative Research and General Counsel
1/28/2019 LFA/ bill sent to agencies for fiscal inputLegislative Research and General Counsel
1/29/2019 House/ received bill from Legislative ResearchClerk of the House
1/29/2019 House/ 1st reading (Introduced)House Rules Committee
1/30/2019 LFA/ fiscal note sent to sponsorHouse Rules Committee
1/30/2019 LFA/ fiscal note publicly availableHouse Rules Committee
1/30/2019 House/ received fiscal note from Fiscal AnalystHouse Rules Committee
2/4/2019 House/ to standing committeeHouse Health and Human Services Committee
2/6/2019 House Comm - Favorable RecommendationHouse Health and Human Services Committee7 0 5
2/7/2019 (11:19:59 AM)House/ committee report favorableHouse Health and Human Services Committee
2/7/2019 (11:20:00 AM)House/ 2nd readingHouse 3rd Reading Calendar for House bills
2/15/2019 (2:09:16 PM)House/ 3rd readingHouse 3rd Reading Calendar for House bills
2/15/2019 (2:09:39 PM)House/ circledHouse 3rd Reading Calendar for House billsVoice vote
2/19/2019 (10:33:29 AM)House/ uncircledHouse 3rd Reading Calendar for House billsVoice vote
2/19/2019 (10:42:19 AM)House/ passed 3rd readingSenate Secretary67 0 8
2/19/2019 (10:42:21 AM)House/ to SenateSenate Secretary
2/20/2019 Senate/ received from HouseWaiting for Introduction in the Senate
2/20/2019 Senate/ 1st reading (Introduced)Senate Rules Committee
2/21/2019 Senate/ to standing committeeSenate Health and Human Services Committee
2/22/2019 Senate Comm - Favorable RecommendationSenate Health and Human Services Committee4 0 4
2/25/2019 (10:17:40 AM)Senate/ committee report favorableSenate Health and Human Services Committee
2/25/2019 (10:17:41 AM)Senate/ placed on 2nd Reading CalendarSenate 2nd Reading Calendar
2/27/2019 (2:31:38 PM)Senate/ 2nd readingSenate 2nd Reading Calendar
2/27/2019 (2:34:01 PM)Senate/ passed 2nd readingSenate 3rd Reading Calendar25 0 4
2/28/2019 (10:55:45 AM)Senate/ 3rd readingSenate 3rd Reading Calendar
2/28/2019 (10:58:10 AM)Senate/ passed 3rd readingSenate President24 0 5
2/28/2019 (10:58:11 AM)Senate/ signed by President/ returned to HouseHouse Speaker
2/28/2019 (10:58:12 AM)Senate/ to HouseHouse Speaker
2/28/2019 House/ received from SenateHouse Speaker
2/28/2019 House/ signed by Speaker/ sent for enrollingLegislative Research and General Counsel / Enrolling
3/5/2019 Bill Received from House for EnrollingLegislative Research and General Counsel / Enrolling
3/5/2019 Draft of Enrolled Bill PreparedLegislative Research and General Counsel / Enrolling
3/20/2019 Enrolled Bill Returned to House or SenateClerk of the House
3/20/2019 House/ enrolled bill to PrintingClerk of the House
3/21/2019 House/ received enrolled bill from PrintingClerk of the House
3/21/2019 House/ to GovernorExecutive Branch - Governor
3/22/2019 Governor SignedLieutenant Governor's office for filing